Bardet-Biedl Syndrome 4 (BBS4) (AA 125-139) Peptid
BBS4
Wirt: Synthetic
BP, Imm
-
- Target Alle BBS4 Produkte
- BBS4 (Bardet-Biedl Syndrome 4 (BBS4))
- Protein Region
- AA 125-139
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunogen (Imm)
- Sequenz
- NEAAKLNQKD WEISH
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
- Target
- BBS4 (Bardet-Biedl Syndrome 4 (BBS4))
- Synonyme
- CG13232 Peptide, Dmel\\CG13232 Peptide, zgc:152964 Peptide, AW537059 Peptide, AW742241 Peptide, D9Ertd464e Peptide, Bardet-Biedl syndrome 4 Peptide, bardet-biedl syndrome 4 Peptide, Bardet-Biedl syndrome 4 (human) Peptide, BBS4 Peptide, bbs4 Peptide, Bbs4 Peptide
-
Sie sind hier:
